BHC
Bausch Health Companies Inc.
+0.03 (+0.62%)5.73USD418K成交股數2.1B市值–本益比(近四季)0.2股價營收比+12.7%營收年增(近四季)2026-10-28下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 1 · 259K · 1 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 392K |
| 近 180 天 淨額 | −392K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-19 | 08-20 | Lenar Aimee J. | President, US Pharma | S 公開市場賣出(10b5-1) | 36.8K | 7.03 | 259K | 335K | SEC |
| 2026-07-17 | 07-20 | Lenar Aimee J. | President, US Pharma | F 繳稅扣股 | 5.3K | 4.83 | 25K | 372K | SEC |
| 2026-07-15 | 07-17 | Lenar Aimee J. | President, US Pharma | F 繳稅扣股 | 23.4K | 4.89 | 114K | 377K | SEC |
| 2026-07-14 | 07-15 | LEE STEVEN HYOSIG | SVP, Controller & CAO | F 繳稅扣股 | 3.1K | 4.75 | 15K | 70.1K | SEC |
| 2026-06-30 | 07-02 | WECHSLER AMY B | Director | A 獲配股票 | 1.4K | 4.93 | 7K | 315K | SEC |
| 2026-06-30 | 07-02 | Paulson John | Director | A 獲配股票 | 12.7K | 4.93 | 62K | 430K | SEC |
| 2026-06-30 | 07-02 | LEUNG SANDRA | Director | A 獲配股票 | 6.8K | 4.93 | 34K | 97.1K | SEC |
| 2026-05-22 | 05-26 | POWER ROBERT N | Director | A 獲配股票 | 45.9K | – | – | 301K | SEC |
| 2026-05-22 | 05-26 | LEUNG SANDRA | Director | A 獲配股票 | 45.9K | – | – | 90.2K | SEC |
| 2026-05-22 | 05-26 | Lee Frank D. | Director | A 獲配股票 | 45.9K | – | – | 95.2K | SEC |
| 2026-05-22 | 05-26 | KAVANAGH SARAH B | Director | A 獲配股票 | 45.9K | – | – | 282K | SEC |
| 2026-05-22 | 05-26 | Paulson John | Director | A 獲配股票 | 45.9K | – | – | 418K | SEC |
| 2026-05-22 | 05-26 | Garcia Christian A | Director | A 獲配股票 | 45.9K | – | – | 136K | SEC |
| 2026-05-22 | 05-26 | ROBERTS EIRY | Director | A 獲配股票 | 45.9K | – | – | 45.9K | SEC |
| 2026-05-22 | 05-26 | WECHSLER AMY B | Director | A 獲配股票 | 45.9K | – | – | 314K | SEC |
| 2026-05-22 | 05-26 | GOETTLER MICHAEL | Director | A 獲配股票 | 45.9K | – | – | 76.0K | SEC |
| 2026-05-19 | 05-20 | Lee Frank D. | Director | S 公開市場賣出(10b5-1) | 24.5K | 5.43 | 133K | 49.3K | SEC |
| 2026-03-31 | 04-02 | Paulson John | Director | A 獲配股票 | 11.6K | 5.40 | 62K | 372K | SEC |
| 2026-03-31 | 04-02 | WECHSLER AMY B | Director | A 獲配股票 | 1.3K | 5.40 | 7K | 268K | SEC |
| 2026-03-31 | 04-02 | LEUNG SANDRA | Director | A 獲配股票 | 5.9K | 5.40 | 32K | 44.4K | SEC |
| 2026-03-03 | 03-03 | Carson Seana | EVP, General Counsel | S 公開市場賣出(10b5-1) | 4.4K | 5.77 | 26K | 617K | SEC |
| 2026-03-02 | 03-03 | Carson Seana | EVP, General Counsel | J 其他 | 138K | 5.95 | 821K | 621K | SEC |
| 2026-03-02 | 03-03 | Carson Seana | EVP, General Counsel | F 繳稅扣股 | 17.0K | 5.95 | 101K | 759K | SEC |
| 2026-03-02 | 03-03 | Carson Seana | EVP, General Counsel | S 公開市場賣出(10b5-1) | 6.9K | 5.78 | 40K | 776K | SEC |
| 2026-03-02 | 03-03 | APPIO THOMAS | Chief Executive Officer | J 其他 | 1.1M | 5.95 | 6.8M | 2.3M | SEC |
| 2026-03-02 | 03-03 | APPIO THOMAS | Chief Executive Officer | F 繳稅扣股 | 83.7K | 5.95 | 498K | 3.5M | SEC |
| 2026-02-27 | 03-03 | Charhon Jean-Jacques | EVP, CFO | F 繳稅扣股 | 49.1K | 5.93 | 291K | 706K | SEC |
| 2026-02-27 | 03-03 | Carson Seana | EVP, General Counsel | F 繳稅扣股 | 26.3K | 5.93 | 156K | 783K | SEC |
| 2026-02-27 | 03-03 | APPIO THOMAS | Chief Executive Officer | F 繳稅扣股 | 83.1K | 5.93 | 493K | 3.5M | SEC |
| 2026-02-27 | 02-27 | Carson Seana | EVP, General Counsel | S 公開市場賣出(10b5-1) | 8.4K | 5.95 | 50K | 809K | SEC |
| 2026-02-26 | 02-27 | APPIO THOMAS | Chief Executive Officer | F 繳稅扣股 | 117K | 6.04 | 704K | 3.6M | SEC |
| 2026-02-26 | 02-27 | Lenar Aimee J. | EVP, US Pharma | F 繳稅扣股 | 17.6K | 6.04 | 106K | 400K | SEC |
| 2026-02-26 | 02-27 | Carson Seana | EVP, General Counsel | F 繳稅扣股 | 32.2K | 6.04 | 195K | 818K | SEC |
| 2026-02-26 | 02-27 | Charhon Jean-Jacques | EVP, CFO | F 繳稅扣股 | 36.0K | 6.04 | 217K | 756K | SEC |
| 2026-02-25 | 02-27 | Charhon Jean-Jacques | EVP, CFO | A 獲配股票 | 276K | – | – | 792K | SEC |
| 2026-02-25 | 02-27 | APPIO THOMAS | Chief Executive Officer | A 獲配股票 | 815K | – | – | 3.7M | SEC |
| 2026-02-25 | 02-27 | LEE STEVEN HYOSIG | SVP, Controller & CAO | A 獲配股票 | 45.9K | – | – | 73.2K | SEC |
| 2026-02-25 | 02-27 | Lenar Aimee J. | EVP, US Pharma | A 獲配股票 | 157K | – | – | 418K | SEC |
| 2026-02-25 | 02-27 | Carson Seana | EVP, General Counsel | A 獲配股票 | 212K | – | – | 850K | SEC |
| 2026-02-09 | 02-11 | Carson Seana | EVP, General Counsel | A 獲配股票 | 138K | – | – | 638K | SEC |
| 2026-02-09 | 02-11 | APPIO THOMAS | Chief Executive Officer | A 獲配股票 | 1.1M | – | – | 2.9M | SEC |
| 2025-12-31 | 01-02 | Paulson John | Director | A 獲配股票 | 9.0K | – | – | 360K | SEC |
| 2025-12-31 | 01-02 | LEUNG SANDRA | Director | A 獲配股票 | 4.6K | – | – | 38.4K | SEC |
| 2025-12-31 | 01-02 | WECHSLER AMY B | Director | A 獲配股票 | 989 | – | – | 266K | SEC |
| 2025-11-25 | 11-28 | PAULSON & CO. INC. | TenPercentOwner | P 公開市場買進 | 2.5M | 6.25 | 15.6M | 73.3M | SEC |
| 2025-09-30 | 10-02 | Paulson John | Director | A 獲配股票 | 9.7K | – | – | 351K | SEC |
| 2025-09-30 | 10-02 | WECHSLER AMY B | Director | A 獲配股票 | 1.1K | – | – | 265K | SEC |
| 2025-09-30 | 10-02 | LEUNG SANDRA | Director | A 獲配股票 | 3.7K | – | – | 33.8K | SEC |
| 2025-09-08 | 09-08 | Carson Seana | EVP, General Counsel | S 公開市場賣出(10b5-1) | 13.4K | 7.31 | 98K | 500K | SEC |
| 2025-09-05 | 09-08 | Carson Seana | EVP, General Counsel | F 繳稅扣股 | 51.3K | 7.35 | 377K | 513K | SEC |
| 2025-08-21 | 08-22 | Lee Frank D. | Director | S 公開市場賣出 | 15.9K | 7.66 | 122K | 73.8K | SEC |
| 2025-08-14 | 08-14 | Paulson John | Director | P 公開市場買進 | 34.7M | 9.00 | 312M | 70.8M | SEC |
| 2025-08-13 | 08-13 | Paulson John | Director | P 公開市場買進 | 86.4K | 7.06 | 610K | 36.0M | SEC |
| 2025-08-12 | 08-13 | Paulson John | Director | P 公開市場買進 | 1.2M | 6.88 | 8.0M | 35.9M | SEC |
| 2025-08-11 | 08-13 | Paulson John | Director | P 公開市場買進 | 2.0M | 6.35 | 12.7M | 34.8M | SEC |
| 2025-07-25 | 07-29 | LEUNG SANDRA | Director | A 獲配股票 | 30.1K | – | – | 30.1K | SEC |
| 2025-07-25 | 07-29 | GOETTLER MICHAEL | Director | A 獲配股票 | 30.1K | – | – | 30.1K | SEC |
| 2025-07-17 | 07-18 | Lenar Aimee J. | EVP, US Pharma | A 獲配股票 | 30.8K | – | – | 261K | SEC |
| 2025-07-15 | 07-16 | Lenar Aimee J. | EVP, US Pharma | F 繳稅扣股 | 22.7K | 6.42 | 146K | 230K | SEC |
| 2025-07-14 | 07-15 | LEE STEVEN HYOSIG | SVP, Controller & CAO | A 獲配股票 | 27.4K | – | – | 27.4K | SEC |
| 2025-06-30 | 07-02 | Paulson John | Director | A 獲配股票 | 9.4K | – | – | 341K | SEC |
| 2025-06-30 | 07-02 | ICAHN BRETT | Director | A 獲配股票 | 4.0K | – | – | 220K | SEC |
| 2025-06-30 | 07-02 | WECHSLER AMY B | Director | A 獲配股票 | 1.0K | – | – | 264K | SEC |
| 2025-06-13 | 06-17 | Paulson John | Director | P 公開市場買進 | 3.6M | 5.94 | 21.2M | 32.8M | SEC |
| 2025-06-12 | 06-12 | Paulson John | Director | P 公開市場買進 | 1.0M | 5.47 | 5.5M | 29.2M | SEC |
| 2025-06-11 | 06-12 | Paulson John | Director | P 公開市場買進 | 1.0M | 5.24 | 5.4M | 28.2M | SEC |
| 2025-06-10 | 06-12 | Paulson John | Director | P 公開市場買進 | 754K | 5.05 | 3.8M | 27.2M | SEC |
| 2025-05-16 | 05-20 | Miller Steven D | Director | A 獲配股票 | 54.3K | – | – | 229K | SEC |
| 2025-05-16 | 05-20 | Paulson John | Director | A 獲配股票 | 54.3K | – | – | 332K | SEC |
| 2025-05-16 | 05-20 | Garcia Christian A | Director | A 獲配股票 | 54.3K | – | – | 89.7K | SEC |
| 2025-05-16 | 05-20 | POWER ROBERT N | Director | A 獲配股票 | 54.3K | – | – | 255K | SEC |
| 2025-05-16 | 05-20 | ICAHN BRETT | Director | A 獲配股票 | 54.3K | – | – | 216K | SEC |
| 2025-05-16 | 05-20 | KAVANAGH SARAH B | Director | A 獲配股票 | 54.3K | – | – | 236K | SEC |
| 2025-05-16 | 05-20 | Lee Frank D. | Director | A 獲配股票 | 54.3K | – | – | 89.7K | SEC |
| 2025-05-16 | 05-20 | WECHSLER AMY B | Director | A 獲配股票 | 54.3K | – | – | 263K | SEC |
| 2025-05-16 | 05-20 | Mulligan Richard | Director | A 獲配股票 | 54.3K | – | – | 156K | SEC |
| 2025-03-31 | 04-01 | ICAHN BRETT | Director | A 獲配股票 | 5.1K | 6.47 | 33K | 162K | SEC |
| 2025-03-31 | 04-01 | WECHSLER AMY B | Director | A 獲配股票 | 1.1K | 6.47 | 7K | 209K | SEC |
| 2025-03-31 | 04-01 | Paulson John | Director | A 獲配股票 | 9.7K | 6.47 | 62K | 278K | SEC |
| 2025-02-28 | 03-03 | Carson Seana | EVP, General Counsel | F 繳稅扣股 | 6.0K | 7.44 | 45K | 608K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| PAULSON & CO. INC. | 73.3M | 361M | 新進 | 新進 |
| GOLDENTREE ASSET MANAGEMENT LP | 34.7M | 171M | 新進 | 新進 |
| ROYAL BANK OF CANADA | 10.8M | 53.4M | 新進 | 新進 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 8.0M | 39.4M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.5M | 36.8M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.8M | 33.2M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 6.2M | 30.7M | 新進 | 新進 |
| MFN Partners Management, LP | 6.0M | 29.6M | 新進 | 新進 |
| Kohlberg Kravis Roberts & Co. L.P. | 5.2M | 25.8M | 新進 | 新進 |
| ING GROEP NV | 5.0M | 24.7M | 新進 | 新進 |
| Hudson Bay Capital Management LP | 5.0M | 24.7M | 新進 | 新進 |
| GENDELL JEFFREY L | 4.0M | 19.9M | 新進 | 新進 |
| 挪威主權基金 NORGES BANK | 3.4M | 16.9M | 新進 | 新進 |
| MACQUARIE GROUP LTD | 3.3M | 16.0M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 3.2M | 16.0M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 2.7M | 13.3M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 2.3M | 11.1M | 新進 | 新進 |
| Point72(柯恩) Point72 Asset Management, L.P. | 2.2M | 11.0M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.2M | 10.8M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 2.1M | 10.5M | 新進 | 新進 |
| PRIVATE MANAGEMENT GROUP INC | 1.7M | 8.3M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 1.7M | 8.3M | 新進 | 新進 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 1.5M | 7.4M | 新進 | 新進 |
| Man Group plc | 1.5M | 7.2M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 1.3M | 6.5M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 220 -6 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 220 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 237M · 63.4% |
| 合計季末市值 | 1.1B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 8.2M |
|---|---|
| 與上期比 | -2.3% |
| 佔流通股數 | 2.20% |
| 日均成交量 | 2.8M |
| 回補天數 | 3.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 8.2M | -2.3% | 2.20% | 2.8M | 3.0 |
| 2026-08-14 | 8.4M | +11.3% | 2.25% | 5.0M | 1.7 |
| 2026-07-31 | 7.6M | +2.6% | 2.02% | 5.1M | 1.5 |
| 2026-07-15 | 7.4M | +0.5% | 1.97% | 2.0M | 3.7 |
| 2026-06-30 | 7.3M | -1.5% | 1.96% | 3.9M | 1.9 |
| 2026-06-15 | 7.4M | +21.5% | 1.99% | 2.2M | 3.4 |
| 2026-05-29 | 6.1M | +2.7% | 1.64% | 1.6M | 3.8 |
| 2026-05-15 | 6.0M | -6.3% | 1.59% | 1.7M | 3.4 |
| 2026-04-30 | 6.4M | +1.4% | 1.70% | 1.9M | 3.4 |
| 2026-04-15 | 6.3M | +4.8% | 1.68% | 1.1M | 5.7 |
| 2026-03-31 | 6.0M | -4.9% | 1.60% | 1.5M | 4.0 |
| 2026-03-13 | 6.3M | +13.7% | 1.68% | 3.2M | 2.0 |
| 2026-02-27 | 5.5M | -1.1% | 1.48% | 2.3M | 2.4 |
| 2026-02-13 | 5.6M | +3.4% | 1.50% | 1.8M | 3.1 |
| 2026-01-30 | 5.4M | +7.7% | 1.45% | 2.7M | 2.0 |
| 2026-01-15 | 5.0M | +4.0% | 1.34% | 1.9M | 2.7 |
| 2025-12-31 | 4.8M | -24.6% | 1.29% | 2.2M | 2.2 |
| 2025-12-15 | 6.4M | +13.5% | 1.71% | 3.2M | 2.0 |
| 2025-11-28 | 5.6M | -14.4% | 1.51% | 2.4M | 2.4 |
| 2025-11-14 | 6.7M | +2.8% | 1.78% | 3.1M | 2.2 |
| 2025-10-31 | 6.5M | -13.2% | 1.73% | 2.5M | 2.6 |
| 2025-10-15 | 7.5M | -3.1% | 2.00% | 1.3M | 5.7 |
| 2025-09-30 | 7.7M | -2.8% | 2.06% | 1.9M | 4.1 |
| 2025-09-15 | 7.9M | -4.0% | 2.12% | 2.0M | 3.9 |
| 2025-08-29 | 8.3M | -0.5% | 2.21% | 2.3M | 3.7 |
| 2025-08-15 | 8.3M | +13.9% | 2.22% | 6.4M | 1.3 |